Scizophrenia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Scizophrenia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Not Yet RecruitingPhase 4

NCT07386080

Carbergoline for Antipsychotic Induced Hyperprolactinemia.

The goal of this clinical trial is to learn if cabergoline is safe to use in patients with antipsychotic-induced hyperprolactinemia in adults with scizophrenia.…

Denmark146 participantsStarted 2026-05-01

Treatment: Cabergoline (Dopamine Agonist), Placebo

CompletedPhase 4

NCT00456937

Escitalopram in Schizophrenia in OCD- Open Label Study

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could b…

Israel15 participantsStarted 2006-07

Treatment: Escitalopram